We are dedicated to developing better medicines for patients and have drug candidates in development across a range of diseases
Our Research and Development strength is our deep understanding of established hormonal biology. This provides leverage to identify a host of novel approaches to target hormone receptors in serious medical conditions where we can develop and commercialize new medicines.
This focus has led to a pipeline of clinical and preclinical product candidates that target and modulate various hormone receptors and have the potential to treat a variety of urologic, endocrine, wasting and inflammatory diseases.
This understanding of the hormone balance in health and disease has led to our lead disease program that is evaluating the effects of androgen modulation in postmenopausal women with stress urinary incontinence. One other earlier stage program that has come from our understanding of hormonal effects includes castration-resistant prostate cancer.